If you have been reading about Thymalfasin and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-09-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
| Property | Value | Notes |
|---|---|---|
| Amino acid length | 28 residues | Single chain with an acetylated N-terminus |
| Molecular mass | Approximately 3,108 Da | Small shifts occur with counter-ion and water content |
| Isoelectric point | Around 3.5 | Low value follows from the many acidic residues |
| Parent molecule | N-terminal region of prothymosin alpha | Free circulating form in humans is not firmly established |
| Common synonyms | Thymalfasin; T alpha 1 | Older literature also uses the full spelled-out form |
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
In 1839, the Daoguang Emperor rejected proposals to legalise and tax opium and ordered imperial commissioner Lin Zexu to eradicate the opium trade. The commissioner destroyed opium stockpiles and halted all foreign trade, triggering a British military response and the First Opium War. The Qing surrendered early in the war and ceded Hong Kong Island in the Convention of Chuenpi, signed by Charles Elliot and Qishan. British forces began controlling Hong Kong shortly after the signing of the convention, on 26 January 1841. However, both countries were dissatisfied and did not ratify the agreement. After more than a year of further hostilities, Hong Kong Island was formally ceded to the United Kingdom in the 1842 Treaty of Nanking. Administrative infrastructure was quickly built by early 1842, but piracy, disease, and hostile Qing policies initially prevented the government from attracting commerce. Conditions on the island improved during the Taiping Rebellion in the 1850s, when many Chinese refugees, including wealthy merchants, fled mainland turbulence and settled in the colony. Further tensions between the British and Qing over the opium trade escalated into the Second Opium War. The Qing were again defeated and were forced to give up Kowloon Peninsula and Stonecutters Island in the Convention of Peking. By the end of this war, Hong Kong had evolved from a transient colonial outpost into a major entrepôt. Rapid economic improvement during the 1850s attracted foreign investment, as potential stakeholders became more confident in Hong Kong's future.
In May of 1893, Wilmot Castle & Company began the production of modified versions of the Arnold Steam Sterilizer designed for the sterilization of baby bottles and pasteurization of cow's milk. The original sterilizer was based on William E, Arnold's Arnold Steam Cooker first patented in 1879. The Sterilizer and Pasteurizer began playing a significant role in pediatric hospital settings throughout the United States. In 1903, researchers documented the Arnold Sterilizer's effectiveness in battling Cholera Infantum. This was caused primarily by contaminated cow's milk resulting in summer-time infant mortality in Boston's slums and across the country. By 1914 the Castle Home Pasteurizer was available for families and written up in Good Housekeeping Magazine. Allen and Hanbury introduced a new bottle design with a removable valve and teat on the two ends in 1894, and an improved model, the Allenbury, in 1900. This "banana" bottle was easier to clean. Sometimes referred to as the "hygienic bottle", it helped to improve survival rates. Similar bottles were introduced by other manufacturers and remained popular from the 1900s to the 1950s. Eventually increased understanding of the causes and transmission of disease and improvements in medicine and public health began to reduce infant mortality. Heat-resistant Pyrex bottles were introduced to the American and British markets at different times. Pyrex bottles were first introduced in the United States by Corning Inc. in 1922.
Alternatively, if the load is moving at a low delta-v relative to the destination, then it can be captured by means of a mass catcher. This could consist of a large, flexible net or inflatable structure that would transfer the momentum of the mass to the larger facility. Once in place, the materials can be moved into place by mechanical means or by means of small thrusters. Materials can be used for manufacturing either in their raw form, or by processing them to extract the constituent elements. Processing techniques include various chemical, thermal, electrolytic, and magnetic methods for separation. In the near term, relatively straightforward methods can be used to extract aluminum, iron, oxygen, and silicon from lunar and asteroidal sources. Less concentrated elements will likely require more advanced processing facilities, which may have to wait until a space manufacturing infrastructure is fully developed. Some of the chemical processes will require a source of hydrogen for the production of water and acid mixtures. Hydrogen gas can also be used to extract oxygen from the lunar regolith, although the process is not very efficient. So a readily available source of useful volatiles is a positive factor in the development of space manufacturing. Alternatively, oxygen can be liberated from the lunar regolith without reusing any imported materials by heating the regolith to 4,530 °F (2,500 °C) in a vacuum. This was tested on Earth with lunar simulant in a vacuum chamber. As much as 20% of the sample was released as free oxygen. Eric Cardiff calls the remainder slag.
A soldier of FC Wing 177 was killed by insurgents in Bajaur District and another FC soldier was killed in South Waziristan, moreover an Elite Force cop was killed in Hangu District. TTP, however claimed to have conducted 16 attacks in South Waziristan, North Waziristan, Karak, Kohat, Bajaur, Peshawar, and Harnai on the day, claiming to have killed 11 Pakistani personnel. A drone strike in Mirali injured two civilians. On 2 July, Pakistani forces intercepted a drone targeting the 134 Wing of Pishin Scouts. A girls school was damaged in an insurgent attack in Bannu District, while an IED targeting a bridge was also neutralized. A drone attack in Bajaur allegedly intended at a Pakistani position, killed three civilians and wounded eight more. Two policemen were killed and one was wounded in a militant ambush in Mohmand District. Khalid Masood, a TTP commander was assassinated by "unidentified attackers" inside Afghanistan in Ghazni District. On 3 July, Pakistani forces killed three insurgents in Bajaur District, while TTP claimed to have assassinated a suspected Pakistani spy in Khyber District. JuA announced its formal split from the TTP. Two FC soldiers were killed in a Taliban sniper attack on the Do Jando border Post in Khyber District. An IED was also defused by Pakistani forces in Wana. On 5 July, heavy fighting between Pakistani and Afghan troops took place in Khyber District, following cross border fire from Afghanistan which wounded three Pakistani soldiers.
Sources: en.wikipedia.org
Major challenges to the use of cecropins as cancer therapeutics are delivery of the peptides to tumor cells. Repeated administration of peptides is necessary to maintain systemic levels of cecropins at sufficient concentrations for anti-cancer activity. This need for repeated administration complicates potential treatment plans. One proposed alternative suggests use of gene therapy to introduce cecropin genes into cancer cells. A study in which cecropin genes were expressed in a human bladder carcinoma cell line showed that tumor cells bearing cecropin genes have reduced tumorigenicity, up to complete loss of tumorigenicity in some cell clones. More recent studies have identified new cecropins, which may be prove useful in development of cancer therapeutics. For example, genome and transcriptome analyses of the spruce budworm Choristoneura fumiferana resulted in identification of novel cecropins which differ from previously characterized cecropins in that they are negatively charged, rather than positively charged. A BH3-like motif (amino acid sequence G-[KQR]-[HKQNR]-[IV]-[KQR]) is present in both anionic and cationic cecropins, and analysis suggests that this motif may interact with Bcl-2, a protein implicated in apoptosis. Further study of cecropin structure and anticancer properties may inform design of novel cancer therapeutics.
== Drinks == Tea (Chinese: 茶 chá) plays an important role in Chinese dining culture. Baijiu and huangjiu are strong alcoholic beverages that are preferred by many people as well. Wine is not as popular as other drinks in China that are consumed while dining, although they are usually available in the menu.
=== Continuing Claim === His only son, Ernest Augustus, Crown Prince of Hanover, inherited the claim upon George's death in 1878. Ernest Augustus was also first in line to the throne of the Duchy of Brunswick, whose rulers had been a junior branch of the House of Hanover. In 1884, that branch became extinct with the death of William, a distant cousin of Ernest Augustus. Since Ernest Augustus refused to renounce his claim to annexed Hanover, the Bundesrat of the German Empire ruled that he would disturb the peace of the empire if he ascended the throne of Brunswick. As a result, Brunswick was ruled by a regency until 1913, when his son, also named Ernest Augustus, married the German Emperor's daughter, Princess Viktoria Luise and swore allegiance to the German Empire. The Duke then renounced his claim to Brunswick in favour of his son, and the Bundesrat allowed the younger Ernest Augustus to take possession of Brunswick as a kind of dowry compensation for Hanover. The German-Hanoverian Party, which at times supported secession from the Reich, demanded a separate status for the province in the Reichstag. The party existed until banned by the Nazi government.
=== With sulfur species === Thionyl chloride will transform sulfinic acids into sulfinyl chlorides Sulfonic acids react with thionyl chloride to produce sulfonyl chlorides. Sulfonyl chlorides have also been prepared from the direct reaction of the corresponding diazonium salt with thionyl chloride. Thionyl chloride can be used in variations of the Pummerer rearrangement.
Furthermore, a similar response-occupancy discrepancy has been observed with methylphenidate, which also stabilizes the dopamine transporter in an open outward-facing conformation. These findings have evoked a hypothesis that cocaine may also function as a so-called "DAT inverse agonist" or "negative allosteric modifier of DAT" resulting in dopamine transporter reversal, and subsequent dopamine release into the synaptic cleft from the axon terminal in a manner similar to but distinct from amphetamines. Sigma receptors are affected by cocaine, as cocaine functions as a sigma ligand agonist. Further specific receptors it has been demonstrated to function on are NMDA and the D1 dopamine receptor. Cocaine also blocks sodium channels, thereby interfering with the propagation of action potentials; thus, like lignocaine and novocaine, it acts as a local anesthetic. It also functions on the binding sites to the dopamine and serotonin sodium dependent transport area as targets as separate mechanisms from its reuptake of those transporters; unique to its local anesthetic value which makes it in a class of functionality different from both its own derived phenyltropanes analogues which have that removed. In addition to this, cocaine has some target binding to the site of the κ-opioid receptor. Cocaine also causes vasoconstriction, thus reducing bleeding during minor surgical procedures. Recent research points to an important role of circadian mechanisms and clock genes in behavioral actions of cocaine.
Sources: en.wikipedia.org
It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.
Prothymosin alpha is a much larger acidic protein, roughly 111 to 113 residues long, and the thymosin alpha-1 sequence matches its N-terminal region. The small peptide is therefore best understood as a fragment of that parent protein rather than a separate gene product.
Trials and clinical reports have examined chronic hepatitis B and C, use as a vaccine adjuvant, and supportive treatment in some immunodeficiency and oncology settings. Results vary by indication, and regulatory approval differs between countries.
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.